Analytical Data
-
Gene name
CGB7
- Application
-
Alternative Names
Choriogonadotropin subunit beta 7
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0DN87
-
Expression Region
56-165aa
-
AA Sequence
GYCPTMTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDCGGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ
-
Molecular Weight
37.84 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CGB7, or chorionic gonadotropin beta subunit 7, is a protein that plays a significant role in reproductive biology, particularly in human pregnancy and fertility. It is one of the subunits of chorionic gonadotropin (hCG), a hormone produced by the placenta shortly after implantation. Research on CGB7 has gained traction due to its involvement in early pregnancy maintenance and its potential applications in reproductive health diagnostics and therapies. Studies have shown that variations in CGB7 expression may correlate with various reproductive disorders, making it an important target for clinical research. Furthermore, understanding the mechanisms underlying CGB7’s function could provide insights into pathophysiological conditions such as ectopic pregnancies, preeclampsia, and infertility. The exploration of CGB7 also intersects with advancements in biotechnology, particularly in the development of recombinant proteins for therapeutic purposes. This research aims to elucidate the structural and functional dynamics of CGB7, paving the way for novel diagnostic tools and targeted treatments. Overall, the study of CGB7 is crucial in enhancing our knowledge of human reproduction and developing strategies to address related health issues.











